Might be time to revisit OPGN, Chart loos great and company should be expecting FDA approval
of their product relatively soon from what I'm reading.
All JMO please DYODD. I am NOT a financial advisor.
of their product relatively soon from what I'm reading.
All JMO please DYODD. I am NOT a financial advisor.